Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 15 entries
Sorted by: Best Match Show Resources per page
Ovarian Adenomatoid Tumor Coexisting with Mature Cystic Teratoma: A Rare Case Report.

Case reports in obstetrics and gynecology

Shi M, Al-Delfi F, Al Shaarani M, Knowles K, Cotelingam J.
PMID: 29085685
Case Rep Obstet Gynecol. 2017;2017:3702682. doi: 10.1155/2017/3702682. Epub 2017 Sep 11.

Adenomatoid tumor of the ovary is rare, and so are collision tumors in this location. The most common histological combination of ovarian collision tumors is the coexistence of mature cystic teratoma with ovarian cystadenoma or cystadenocarcinoma. Presented herein is...

Cite
Shi M, Al-Delfi F, Al Shaarani M, et al. Ovarian Adenomatoid Tumor Coexisting with Mature Cystic Teratoma: A Rare Case Report. Case Rep Obstet Gynecol. 2017;2017:3702682doi: 10.1155/2017/3702682.
Shi, M., Al-Delfi, F., Al Shaarani, M., Knowles, K., & Cotelingam, J. (2017). Ovarian Adenomatoid Tumor Coexisting with Mature Cystic Teratoma: A Rare Case Report. Case reports in obstetrics and gynecology, 20173702682. https://doi.org/10.1155/2017/3702682
Shi, Mingxia, et al. "Ovarian Adenomatoid Tumor Coexisting with Mature Cystic Teratoma: A Rare Case Report." Case reports in obstetrics and gynecology vol. 2017 (2017): 3702682. doi: https://doi.org/10.1155/2017/3702682
Shi M, Al-Delfi F, Al Shaarani M, Knowles K, Cotelingam J. Ovarian Adenomatoid Tumor Coexisting with Mature Cystic Teratoma: A Rare Case Report. Case Rep Obstet Gynecol. 2017;2017:3702682. doi: 10.1155/2017/3702682. Epub 2017 Sep 11. PMID: 29085685; PMCID: PMC5611868.
Copy Download .nbib Format: NLM
Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant.

Case reports in oncology

Master S, Leary C, Takalkar A, Coltelingam J, Mansour R, Mills GM, Koshy N.
PMID: 28690529
Case Rep Oncol. 2017 Jun 19;10(2):534-541. doi: 10.1159/000477338. eCollection 2017.

Patients with chronic lymphocytic leukemia (CLL) who progress to Richter transformation (RT) have a poor prognosis. Multi-agent chemotherapy regimens do not have good response rates. There are few case reports on the use of ibrutinib in RT. Here, we...

Cite
Master S, Leary C, Takalkar A, et al. Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant. Case Rep Oncol. 2017;10(2):534-541doi: 10.1159/000477338.
Master, S., Leary, C., Takalkar, A., Coltelingam, J., Mansour, R., Mills, G. M., & Koshy, N. (2017). Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant. Case reports in oncology, 10(2), 534-541. https://doi.org/10.1159/000477338
Master, Samip, et al. "Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant." Case reports in oncology vol. 10,2 (2017): 534-541. doi: https://doi.org/10.1159/000477338
Master S, Leary C, Takalkar A, Coltelingam J, Mansour R, Mills GM, Koshy N. Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant. Case Rep Oncol. 2017 Jun 19;10(2):534-541. doi: 10.1159/000477338. eCollection 2017. PMID: 28690529; PMCID: PMC5498945.
Copy Download .nbib Format: NLM
Pediatric Pulmonary Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: A Case Report and Review of the Literature.

Case reports in pathology

Wei EX, Silva RF, Cotelingam JD, Shackelford RE.
PMID: 29119031
Case Rep Pathol. 2017;2017:8946807. doi: 10.1155/2017/8946807. Epub 2017 Oct 08.

Non-Hodgkin's lymphoma (NHL) is a common malignancy of childhood; however, a lung primary presentation is an uncommon finding, as is finding an association with the Epstein-Barr virus (EBV). We report the case of a 23-month-old female who developed EBV-associated...

Cite
Wei EX, Silva RF, Cotelingam JD, et al. Pediatric Pulmonary Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: A Case Report and Review of the Literature. Case Rep Pathol. 2017;2017:8946807doi: 10.1155/2017/8946807.
Wei, E. X., Silva, R. F., Cotelingam, J. D., & Shackelford, R. E. (2017). Pediatric Pulmonary Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: A Case Report and Review of the Literature. Case reports in pathology, 20178946807. https://doi.org/10.1155/2017/8946807
Wei, Eric X, et al. "Pediatric Pulmonary Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: A Case Report and Review of the Literature." Case reports in pathology vol. 2017 (2017): 8946807. doi: https://doi.org/10.1155/2017/8946807
Wei EX, Silva RF, Cotelingam JD, Shackelford RE. Pediatric Pulmonary Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: A Case Report and Review of the Literature. Case Rep Pathol. 2017;2017:8946807. doi: 10.1155/2017/8946807. Epub 2017 Oct 08. PMID: 29119031; PMCID: PMC5651110.
Copy Download .nbib Format: NLM
Treatment-related MDS/AML in a patient after treatment for large-cell neuroendocrine lung cancer.

The Journal of community and supportive oncology

Ansari J, Ravipati HP, Munker R, Cotelingam JD, Shackelford RE, Prouty LA.
PMID: 26863022
J Community Support Oncol. 2015 Nov;13(11):411-4. doi: 10.12788/jcso.0189.

Secondary leukemia is a common late complication after exposure to cancer therapies such as chemotherapy and radiotherapy. With the increase in the overall survival of cancer patients over the past 3 decades, treatment-related malignant neoplasms have increased in incidence....

Cite
Ansari J, Ravipati HP, Munker R, et al. Treatment-related MDS/AML in a patient after treatment for large-cell neuroendocrine lung cancer. J Community Support Oncol. 2015;13(11):411-4doi: 10.12788/jcso.0189.
Ansari, J., Ravipati, H. P., Munker, R., Cotelingam, J. D., Shackelford, R. E., & Prouty, L. A. (2015). Treatment-related MDS/AML in a patient after treatment for large-cell neuroendocrine lung cancer. The Journal of community and supportive oncology, 13(11), 411-4. https://doi.org/10.12788/jcso.0189
Ansari, Junaid, et al. "Treatment-related MDS/AML in a patient after treatment for large-cell neuroendocrine lung cancer." The Journal of community and supportive oncology vol. 13,11 (2015): 411-4. doi: https://doi.org/10.12788/jcso.0189
Ansari J, Ravipati HP, Munker R, Cotelingam JD, Shackelford RE, Prouty LA. Treatment-related MDS/AML in a patient after treatment for large-cell neuroendocrine lung cancer. J Community Support Oncol. 2015 Nov;13(11):411-4. doi: 10.12788/jcso.0189. PMID: 26863022.
Copy Download .nbib Format: NLM
Malignant Melanoma with Concurrent BRAF E586K and NRAS Q81K Mutations.

Case reports in oncology

Shackelford R, Pollen M, Vora M, Jusion TT, Cotelingam J, Nair B.
PMID: 24926260
Case Rep Oncol. 2014 May 08;7(2):297-300. doi: 10.1159/000362788. eCollection 2014 May.

Cutaneous melanoma is an aggressive malignant tumor of melanocytes which accounts for 80% of skin cancer-related deaths. A number of driver mutations have been identified in melanoma, with the mutually exclusive BRAF V600E and NRAS Q61A mutations together accounting...

Cite
Shackelford R, Pollen M, Vora M, et al. Malignant Melanoma with Concurrent BRAF E586K and NRAS Q81K Mutations. Case Rep Oncol. 2014;7(2):297-300doi: 10.1159/000362788.
Shackelford, R., Pollen, M., Vora, M., Jusion, T. T., Cotelingam, J., & Nair, B. (2014). Malignant Melanoma with Concurrent BRAF E586K and NRAS Q81K Mutations. Case reports in oncology, 7(2), 297-300. https://doi.org/10.1159/000362788
Shackelford, Rodney, et al. "Malignant Melanoma with Concurrent BRAF E586K and NRAS Q81K Mutations." Case reports in oncology vol. 7,2 (2014): 297-300. doi: https://doi.org/10.1159/000362788
Shackelford R, Pollen M, Vora M, Jusion TT, Cotelingam J, Nair B. Malignant Melanoma with Concurrent BRAF E586K and NRAS Q81K Mutations. Case Rep Oncol. 2014 May 08;7(2):297-300. doi: 10.1159/000362788. eCollection 2014 May. PMID: 24926260; PMCID: PMC4035678.
Copy Download .nbib Format: NLM
Marked retroperitoneal lymphadenopathy in hairy cell leukemia: a case report.

Case reports in oncology

Shackelford RE, Heldmann M, Eskandari F, Joshi N, Browning J, Maxwell N, Coteligam J.
PMID: 24163667
Case Rep Oncol. 2013 Sep 28;6(3):493-6. doi: 10.1159/000355434. eCollection 2013.

Hairy cell leukemia (HCL) is uncommonly associated with lymphadenopathy, while retroperitoneal lymphadenopathy is extremely uncommon. We report on a patient with a 12-year history of HCL who developed painless jaundice and ascites, accompanied by positional discomfort with persistent nausea....

Cite
Shackelford RE, Heldmann M, Eskandari F, et al. Marked retroperitoneal lymphadenopathy in hairy cell leukemia: a case report. Case Rep Oncol. 2013;6(3):493-6doi: 10.1159/000355434.
Shackelford, R. E., Heldmann, M., Eskandari, F., Joshi, N., Browning, J., Maxwell, N., & Coteligam, J. (2013). Marked retroperitoneal lymphadenopathy in hairy cell leukemia: a case report. Case reports in oncology, 6(3), 493-6. https://doi.org/10.1159/000355434
Shackelford, R E, et al. "Marked retroperitoneal lymphadenopathy in hairy cell leukemia: a case report." Case reports in oncology vol. 6,3 (2013): 493-6. doi: https://doi.org/10.1159/000355434
Shackelford RE, Heldmann M, Eskandari F, Joshi N, Browning J, Maxwell N, Coteligam J. Marked retroperitoneal lymphadenopathy in hairy cell leukemia: a case report. Case Rep Oncol. 2013 Sep 28;6(3):493-6. doi: 10.1159/000355434. eCollection 2013. PMID: 24163667; PMCID: PMC3806691.
Copy Download .nbib Format: NLM
Bilateral Eagle Syndrome.

Ear, nose, & throat journal

Dabrowski DS, Ghali GE, Cotelingam JD.
PMID: 33258676
Ear Nose Throat J. 2020 Dec 01;145561320973551. doi: 10.1177/0145561320973551. Epub 2020 Dec 01.

Significance StatementUnilateral Eagle Syndrome is relatively rare and highlights important concepts in anatomy and pathophysiology. Bilateral Eagle Syndrome is exponentially more rare and has only been mentioned several times in the literature. Understanding the impact this can have on...

Cite
Dabrowski DS, Ghali GE, Cotelingam JD. Bilateral Eagle Syndrome. Ear Nose Throat J. 2020;145561320973551doi: 10.1177/0145561320973551.
Dabrowski, D. S., Ghali, G. E., & Cotelingam, J. D. (2020). Bilateral Eagle Syndrome. Ear, nose, & throat journal, 145561320973551. https://doi.org/10.1177/0145561320973551
Dabrowski, Dominik S, et al. "Bilateral Eagle Syndrome." Ear, nose, & throat journal vol. (2020): 145561320973551. doi: https://doi.org/10.1177/0145561320973551
Dabrowski DS, Ghali GE, Cotelingam JD. Bilateral Eagle Syndrome. Ear Nose Throat J. 2020 Dec 01;145561320973551. doi: 10.1177/0145561320973551. Epub 2020 Dec 01. PMID: 33258676.
Copy Download .nbib Format: NLM
[No title available]

Case reports in hematology

Wei EX, Leventaki V, Choi JK, Raimondi SC, Azzato EM, Shurtleff SA, Ong MG, Veillon DM, Cotelingam JD, Shackelford RE.
PMID: 29147589
Case Rep Hematol. 2017;2017:5873015. doi: 10.1155/2017/5873015. Epub 2017 Sep 24.

Gamma delta (

Cite
Wei EX, Leventaki V, Choi JK, et al. . Case Rep Hematol. 2017;2017:5873015doi: 10.1155/2017/5873015.
Wei, E. X., Leventaki, V., Choi, J. K., Raimondi, S. C., Azzato, E. M., Shurtleff, S. A., Ong, M. G., Veillon, D. M., Cotelingam, J. D., & Shackelford, R. E. (2017). . Case reports in hematology, 20175873015. https://doi.org/10.1155/2017/5873015
Wei, Eric X, et al. "." Case reports in hematology vol. 2017 (2017): 5873015. doi: https://doi.org/10.1155/2017/5873015
Wei EX, Leventaki V, Choi JK, Raimondi SC, Azzato EM, Shurtleff SA, Ong MG, Veillon DM, Cotelingam JD, Shackelford RE. . Case Rep Hematol. 2017;2017:5873015. doi: 10.1155/2017/5873015. Epub 2017 Sep 24. PMID: 29147589; PMCID: PMC5632927.
Copy Download .nbib Format: NLM
A Twenty-Four-Year-Old Woman with Left Flank Lipoma-Like Hibernoma.

Case reports in oncology

Shackelford RE, Al Shaarani M, Ansari J, Wei E, Cotelingam J.
PMID: 28626403
Case Rep Oncol. 2017 May 09;10(2):438-441. doi: 10.1159/000475708. eCollection 2017.

A 24-year-old woman presented with a 5-month history of a left flank mass that was painful on palpation. Magnetic resonance imaging revealed a 10.0 × 6.0 × 2.5 cm mass consistent with lipoma. A fatty lobulated mass was excised...

Cite
Shackelford RE, Al Shaarani M, Ansari J, et al. A Twenty-Four-Year-Old Woman with Left Flank Lipoma-Like Hibernoma. Case Rep Oncol. 2017;10(2):438-441doi: 10.1159/000475708.
Shackelford, R. E., Al Shaarani, M., Ansari, J., Wei, E., & Cotelingam, J. (2017). A Twenty-Four-Year-Old Woman with Left Flank Lipoma-Like Hibernoma. Case reports in oncology, 10(2), 438-441. https://doi.org/10.1159/000475708
Shackelford, R E, et al. "A Twenty-Four-Year-Old Woman with Left Flank Lipoma-Like Hibernoma." Case reports in oncology vol. 10,2 (2017): 438-441. doi: https://doi.org/10.1159/000475708
Shackelford RE, Al Shaarani M, Ansari J, Wei E, Cotelingam J. A Twenty-Four-Year-Old Woman with Left Flank Lipoma-Like Hibernoma. Case Rep Oncol. 2017 May 09;10(2):438-441. doi: 10.1159/000475708. eCollection 2017. PMID: 28626403; PMCID: PMC5471793.
Copy Download .nbib Format: NLM
Systemic and primary cutaneous anaplastic large cell lymphoma: Clinical features, morphological spectrum, and immunohistochemical profile.

South Asian journal of cancer

Kwatra KS, Paul PAM, Calton N, John JM, Cotelingam JD.
PMID: 28975123
South Asian J Cancer. 2017 Jul-Sep;6(3):129-131. doi: 10.4103/2278-330X.214575.

BACKGROUND: T-cell lymphomas with anaplastic morphology typically comprise of anaplastic lymphoma kinase positive, anaplastic large cell lymphoma (ALK+ ALCL), ALK-negative ALCL (ALK- ALCL), and primary cutaneous ALCL (PC-ALCL). However, other entities such as diffuse large B-cell lymphoma, peripheral T-cell...

Cite
Kwatra KS, Paul PAM, Calton N, et al. Systemic and primary cutaneous anaplastic large cell lymphoma: Clinical features, morphological spectrum, and immunohistochemical profile. South Asian J Cancer. 2017;6(3):129-131doi: 10.4103/2278-330X.214575.
Kwatra, K. S., Paul, P. A. M., Calton, N., John, J. M., & Cotelingam, J. D. (2017). Systemic and primary cutaneous anaplastic large cell lymphoma: Clinical features, morphological spectrum, and immunohistochemical profile. South Asian journal of cancer, 6(3), 129-131. https://doi.org/10.4103/2278-330X.214575
Kwatra, Kanwardeep Singh, et al. "Systemic and primary cutaneous anaplastic large cell lymphoma: Clinical features, morphological spectrum, and immunohistochemical profile." South Asian journal of cancer vol. 6,3 (2017): 129-131. doi: https://doi.org/10.4103/2278-330X.214575
Kwatra KS, Paul PAM, Calton N, John JM, Cotelingam JD. Systemic and primary cutaneous anaplastic large cell lymphoma: Clinical features, morphological spectrum, and immunohistochemical profile. South Asian J Cancer. 2017 Jul-Sep;6(3):129-131. doi: 10.4103/2278-330X.214575. PMID: 28975123; PMCID: PMC5615884.
Copy Download .nbib Format: NLM
Acute Myelogenous Leukemia without Maturation with a Retinoic Alpha-Receptor Deletion: A Case Report.

Case reports in oncology

Trosclair C, Pollen M, Capraro G, Cotelingam J, Shackelford RE.
PMID: 25076892
Case Rep Oncol. 2014 Jun 25;7(2):407-9. doi: 10.1159/000365002. eCollection 2014 May.

Acute promyelocytic leukemia (APL) is characterized by a t(15;17) which fuses the 17q retinoic acid alpha-receptor sequence to the 15q PML gene sequence. The resulting fusion product plays a role in the development and maintenance of APL, and is...

Cite
Trosclair C, Pollen M, Capraro G, et al. Acute Myelogenous Leukemia without Maturation with a Retinoic Alpha-Receptor Deletion: A Case Report. Case Rep Oncol. 2014;7(2):407-9doi: 10.1159/000365002.
Trosclair, C., Pollen, M., Capraro, G., Cotelingam, J., & Shackelford, R. E. (2014). Acute Myelogenous Leukemia without Maturation with a Retinoic Alpha-Receptor Deletion: A Case Report. Case reports in oncology, 7(2), 407-9. https://doi.org/10.1159/000365002
Trosclair, Christopher, et al. "Acute Myelogenous Leukemia without Maturation with a Retinoic Alpha-Receptor Deletion: A Case Report." Case reports in oncology vol. 7,2 (2014): 407-9. doi: https://doi.org/10.1159/000365002
Trosclair C, Pollen M, Capraro G, Cotelingam J, Shackelford RE. Acute Myelogenous Leukemia without Maturation with a Retinoic Alpha-Receptor Deletion: A Case Report. Case Rep Oncol. 2014 Jun 25;7(2):407-9. doi: 10.1159/000365002. eCollection 2014 May. PMID: 25076892; PMCID: PMC4107820.
Copy Download .nbib Format: NLM
Primary Pulmonary Leiomyosarcoma in a Forty-Year-Old Woman.

Case reports in oncology

Ozluk E, Wei EX, Cotelingam J, Shackelford RE.
PMID: 34720937
Case Rep Oncol. 2021 Sep 20;14(3):1333-1336. doi: 10.1159/000516273. eCollection 2021.

Primary pulmonary leiomyosarcomas (PPLs) are rare aggressive malignancies originating from the smooth muscle cells of the pulmonary interstitium, bronchial tree, or blood vessels. Accounting for

Cite
Ozluk E, Wei EX, Cotelingam J, et al. Primary Pulmonary Leiomyosarcoma in a Forty-Year-Old Woman. Case Rep Oncol. 2021;14(3):1333-1336doi: 10.1159/000516273.
Ozluk, E., Wei, E. X., Cotelingam, J., & Shackelford, R. E. (2021). Primary Pulmonary Leiomyosarcoma in a Forty-Year-Old Woman. Case reports in oncology, 14(3), 1333-1336. https://doi.org/10.1159/000516273
Ozluk, Ekin, et al. "Primary Pulmonary Leiomyosarcoma in a Forty-Year-Old Woman." Case reports in oncology vol. 14,3 (2021): 1333-1336. doi: https://doi.org/10.1159/000516273
Ozluk E, Wei EX, Cotelingam J, Shackelford RE. Primary Pulmonary Leiomyosarcoma in a Forty-Year-Old Woman. Case Rep Oncol. 2021 Sep 20;14(3):1333-1336. doi: 10.1159/000516273. eCollection 2021. PMID: 34720937; PMCID: PMC8525287.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 15 entries